COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2384: Articles 23831-23840  | Next

A lesson from COVID-19 on inaccessibility of web-based information for disabled populations worldwide
Dror, A. A., Layous, E., Mizrachi, M., Daoud, A., Eisenbach, N., Morozov, N. G., Srouji, S., Avraham, K. B., Sela, E.
10.1101/2020.08.16.252676 — Posted: 2020-08-17
SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways
Han, L., Zhuang, M.-W., Zheng, Y., Zhang, J., Nan, M.-L., Wang, P.-H., Gao, C.
10.1101/2020.08.16.252973 — Posted: 2020-08-17
COVID-19 among nursing staff: Settings and regional differences
Hoedl, M., Eglseer, D., Bauer, S.
10.1101/2020.08.14.20174797 — Posted: 2020-08-17
A data-driven epidemiological model to explain the Covid-19 pandemic in multiple countries and help in choosing mitigation strategies
Beira, M. J., Kumar, A., Perfeito, L., Goncalves-Sa, J., Sebastiao, P. J.
10.1101/2020.08.15.20175588 — Posted: 2020-08-17
SARS-Coronavirus-2 nucleocapsid protein measured in blood using a Simoa ultra-sensitive immunoassay differentiates COVID-19 infection with high clinical sensitivity.
Shan, D., Johnson, J. M., Fernandes, S. C., Mendes, M., Suib, H., Holdridge, M., Burke, E. M., Beauregard, K. G., Zhang, Y., Cleary, M., Xu, S., Yao, X., Patel, P. P., Plavina, T., Wilson, D. H., Chang, L., Kaiser, K. M., Natterman, J., Schmidt, S. V., Latz, E., Hrusovsky, K., Mattoon, D., Ball, A. J.
10.1101/2020.08.14.20175356 — Posted: 2020-08-17
Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia
Mohana, A., Suliman, T., Mahmoud, N., Hassanein, M., Alfaifi, A., Alenazi, E., Radwan, N., Alkhalifah, N., Elkady, E., Almohaizeie, A., AboGazalah, F., AbdulKareem, K., AlGhofaili, F., Jokhdar, H., Alrabiah, F.
10.1101/2020.08.16.20175752 — Posted: 2020-08-17
The effect of smoking on COVID-19 symptom severity: Systematic review and meta-analysis
Gulsen, A., Arpinar Yigitbas, B., Uslu, B., Droemann, D., Kilinc, O.
10.1101/2020.08.15.20102699 — Posted: 2020-08-17 Discussion: Onsite
Pulmonary cavitation; an under-recognized late complication of severe COVID-19 lung disease
Zoumot, Z., Bonilla, M.-F., Wahla, A. S., Shafiq, I., Uzbeck, M., El-Lababidi, R. M., Hamed, F., Abuzakouk, M., El-Kaissi, M.
10.1101/2020.08.15.20175869 — Posted: 2020-08-17
Efficient Deep Network Architecture for COVID-19 Detection Using Computed Tomography Images
Goel, C., Kumar, A., Dubey, S. K., Srivastava, V.
10.1101/2020.08.14.20170290 — Posted: 2020-08-17
Impact of COVID-19 on Primary Care Mental Health Services: A Descriptive, Cross-Sectional Timeseries of Electronic Healthcare Records
Bauer-Staeb, C. M. M., Davis, A., Smith, T. R., Betts, D., Wilsher, W., Eldridge, C., Griffith, E., Faraway, J. J., Button, K. S.
10.1101/2020.08.15.20175562 — Posted: 2020-08-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).